who knows why, page-2

I wonder if psd is suffering a bit because other biotechs are taking the insto's funds atm.

pgl and avx have been soaking up funds, and acl might do the same tomorrow, if their cancer results are good.

In the long run however, the biotech sectors success will help psd.